(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CYLYSE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CYLYSE

ST13

US500000079184054

Class

1, 5

Filing

79184054

Registration

5139473

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

07/02/2026

Trademark type

Word

Nice classes

1, 5

Filing date

12/11/2015

Registration date

02/14/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/07/2023

Last transaction

07/02/2026

Responsible office

United States Patent and Trademark Office

Status code

707

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

Hyogo 651-0073, JP

Examiner

SEVERSON, JUSTIN

Law office

M20

Holders and representatives

Holders

S. C. (pessoa física)
S. C. (pessoa física)

Representatives

Boyuan W. Wang Procopio Cory Hargreaves & Savitch LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical reagentsexcept for medical or veterinary purposes; chemical reagents for laboratory or research purposes; diagnostic reagents and preparationsexcept for medical or veterinary purposes; hemolytic agents for laboratory or research purposes

Class 5

Chemical reagents for medical or veterinary purposes; diagnostic reagents for medical or veterinary purposes; in vitro diagnostic preparations and reagents for medical or veterinary purposes; hemolytic agents for medical or veterinary purposes

Publications

History of USPTO decisions and trademark events.

33 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/02/2026

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

02/15/2026

RNWL

INTERNATIONAL REGISTRATION RENEWED

09/18/2025

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

06/02/2024

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

05/11/2024

INPC

INVALIDATION PROCESSED

05/11/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

05/07/2024

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

09/07/2023

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

09/07/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/28/2023

ES71

TEAS SECTION 71 RECEIVED

02/06/2023

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

06/09/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/19/2017

FIMP

FINAL DISPOSITION PROCESSED

05/19/2017

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/14/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

02/14/2017

PUBO

PUBLISHED FOR OPPOSITION

11/29/2016

NPUB

NOTICE OF PUBLICATION

11/09/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/26/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/20/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/20/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/20/2016

ALIE

ASSIGNED TO LIE

10/14/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/05/2016

RFNT

REFUSAL PROCESSED BY IB

05/14/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/05/2016

RFRR

REFUSAL PROCESSED BY MPU

04/05/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/05/2016

CNRT

NON-FINAL ACTION WRITTEN

04/04/2016

DOCK

ASSIGNED TO EXAMINER

03/29/2016

MAFR

APPLICATION FILING RECEIPT MAILED

03/15/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/10/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/03/2016

Continuous trademark protection

Get notified about every new filing that threatens CYLYSE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.